Thomas Löning

7.2k total citations · 1 hit paper
137 papers, 5.4k citations indexed

About

Thomas Löning is a scholar working on Oncology, Surgery and Molecular Biology. According to data from OpenAlex, Thomas Löning has authored 137 papers receiving a total of 5.4k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Oncology, 44 papers in Surgery and 33 papers in Molecular Biology. Recurrent topics in Thomas Löning's work include Salivary Gland Tumors Diagnosis and Treatment (25 papers), Cancer-related Molecular Pathways (24 papers) and Ear and Head Tumors (16 papers). Thomas Löning is often cited by papers focused on Salivary Gland Tumors Diagnosis and Treatment (25 papers), Cancer-related Molecular Pathways (24 papers) and Ear and Head Tumors (16 papers). Thomas Löning collaborates with scholars based in Germany, United States and Sweden. Thomas Löning's co-authors include Karin Milde‐Langosch, Ana‐Maria Bamberger, Lutz Riethdorf, Jörn Bullerdiek, Sabine Riethdorf, André Fehr, Christoph Wagener, Christoph M. Bamberger, Jürgen C. Becker and Göran Stenman and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Thomas Löning

134 papers receiving 5.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Analysis of Oral Papillomas, Leukoplakias, and Invasive Carcinomas for Human Papillomavirus Type Related DNA

1985 227 citations Thomas Löning, Jürgen C. Becker et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thomas Löning Germany	44	2.2k	1.7k	1.6k	999	694	137	5.4k
Kathleen T. Montone United States	36	1.9k 0.9×	1.1k 0.7×	1.5k 0.9×	488 0.5×	762 1.1×	115	4.5k
G. Peter Vooijs Netherlands	35	972 0.4×	973 0.6×	1.6k 1.0×	882 0.9×	534 0.8×	134	4.7k
Haruo Ohtani Japan	44	3.7k 1.7×	1.0k 0.6×	2.0k 1.2×	499 0.5×	1.2k 1.7×	161	8.2k
E. Kaiserling Germany	40	1.3k 0.6×	819 0.5×	781 0.5×	519 0.5×	149 0.2×	212	5.2k
Sean K. Lau United States	30	1.1k 0.5×	1.2k 0.7×	822 0.5×	354 0.4×	652 0.9×	81	3.6k
Sara I. Pai United States	41	2.8k 1.3×	1.8k 1.1×	2.0k 1.2×	1.3k 1.3×	733 1.1×	141	7.5k
Cecilia M. Fenoglio United States	34	1.5k 0.7×	1.4k 0.9×	607 0.4×	1.2k 1.2×	206 0.3×	84	4.9k
Steven D. Billings United States	36	1.9k 0.9×	618 0.4×	749 0.5×	408 0.4×	253 0.4×	239	4.8k
Thomas A. Seemayer Canada	46	1.3k 0.6×	1.4k 0.8×	1.0k 0.7×	603 0.6×	297 0.4×	153	6.4k
Dimitry Spitkovsky Germany	28	1.7k 0.8×	668 0.4×	1.7k 1.1×	1.2k 1.2×	405 0.6×	44	3.6k

Countries citing papers authored by Thomas Löning

Since Specialization

Citations

This map shows the geographic impact of Thomas Löning's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Löning with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Löning more than expected).

Fields of papers citing papers by Thomas Löning

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Löning. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Löning. The network helps show where Thomas Löning may publish in the future.

Co-authorship network of co-authors of Thomas Löning

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Löning. A scholar is included among the top collaborators of Thomas Löning based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Löning. Thomas Löning is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Boecker, Werner, Katharina Tiemann, Joerg Boecker, et al.. (2020). Cellular organization and histogenesis of adenosquamous carcinoma of the pancreas: evidence supporting the squamous metaplasia concept. Histochemistry and Cell Biology. 154(1). 97–105. 9 indexed citations

Lax, Sigurd, Lars‐Christian Horn, & Thomas Löning. (2016). Kategorisierung der Tumoren der Cervix uteri. Der Pathologe. 37(6). 573–584. 13 indexed citations

Oliveira‐Ferrer, Leticia, et al.. (2015). Cadherin-11 mRNA and protein expression in ovarian tumors of different malignancy: No evidence of oncogenic or tumor-suppressive function. Molecular and Clinical Oncology. 3(5). 1067–1072. 6 indexed citations

Trocchi, Pietro, Giske Ursin, Oliver Kuß, et al.. (2012). Mammographic density and inter-observer variability of pathologic evaluation of core biopsies among women with mammographic abnormalities. BMC Cancer. 12(1). 554–554. 3 indexed citations

Altevogt, Peter, et al.. (2011). Glycoconjugate expression in adenoid cystic carcinoma of the salivary glands: up‐regulation of L1 predicts fatal prognosis. Histopathology. 59(2). 299–307. 8 indexed citations

Schmidt, Dietmar, Alexander Luyten, Axel Reinecke‐Lüthge, et al.. (2011). Triaging Pap cytology negative, HPV positive cervical cancer screening results with p16/Ki-67 Dual-stained cytology. Gynecologic Oncology. 121(3). 505–509. 167 indexed citations

Löning, Thomas, et al.. (2009). Expression and prognostic value of activating transcription factor 2 (ATF2) and its phosphorylated form in mammary carcinomas.. PubMed. 29(1). 183–9. 18 indexed citations

Fehr, André, Anke Meyer, Klaus Heidorn, et al.. (2009). A link between the expression of the stem cell marker HMGA2, grading, and the fusion CRTC1‐MAML2 in mucoepidermoid carcinoma. Genes Chromosomes and Cancer. 48(9). 777–785. 12 indexed citations

Röser, Kerstin, Thomas Löning, Bauke Ylstra, et al.. (2008). Copy number gain at 8q12.1‐q22.1 is associated with a malignant tumor phenotype in salivary gland myoepitheliomas. Genes Chromosomes and Cancer. 48(2). 202–212. 13 indexed citations

10.

Wöelfle, Ute, Elisabeth Breit, Marcus Otte, et al.. (2005). Bi-specific immunomagnetic enrichment of micrometastatic tumour cell clusters from bone marrow of cancer patients. Journal of Immunological Methods. 300(1-2). 136–145. 40 indexed citations

11.

Stöter, Martin, Ana‐Maria Bamberger, Daniel Speidel, et al.. (2005). Inhibition of casein kinase I delta alters mitotic spindle formation and induces apoptosis in trophoblast cells. Oncogene. 24(54). 7964–7975. 48 indexed citations

12.

Milde‐Langosch, Karin, et al.. (2004). The Role of the AP-1 Transcription Factors c-Fos, FosB, Fra-1 and Fra-2 in the Invasion Process of Mammary Carcinomas. Breast Cancer Research and Treatment. 86(2). 139–152. 105 indexed citations

13.

Löning, Thomas, Lutz Riethdorf, & G. Dhom. (2001). Pathologie des Uterus, der Vagina und Vulva. Springer eBooks. 1 indexed citations

14.

Milde‐Langosch, Karin, Sabine Riethdorf, & Thomas Löning. (2000). Association of human papillomavirus infection with carcinoma of the cervix uteri and its precursor lesions: theoretical and practical implications. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 437(3). 227–233. 37 indexed citations

15.

Lisboa, B., et al.. (1997). Molecular and immunohistochemical analysis of p53 mutations in scrapings and tissue from preinvasive and invasive breast cancer. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 431(6). 375–381. 23 indexed citations

16.

Meißner, K., Thomas Löning, & W. Rehpenning. (1991). [Mycosis fungoides and Sézary syndrome: diagnostic and prognostic relevance of cellular antigen expression].. PubMed. 42(2). 84–91. 2 indexed citations

17.

Milde‐Langosch, Karin, et al.. (1991). [Demonstration and biological significance of viral and cellular oncogenes in uterine carcinomas].. PubMed. 75. 363–5. 1 indexed citations

18.

Rivière, Alain, Jürgen C. Becker, & Thomas Löning. (1991). Comparative investigation of c-erbB2/neu expression in head and neck tumors and mammary cancer. Cancer. 67(8). 2142–2149. 39 indexed citations

19.

Meißner, K., A. Riviére, Gerald Haupt, & Thomas Löning. (1990). Study of neu-protein expression in mammary Paget's disease with and without underlying breast carcinoma and in extramammary Paget's disease.. PubMed. 137(6). 1305–9. 46 indexed citations

20.

Rivière, Alain, et al.. (1990). Expression of c‐erbB2 and c‐myc in squamous epithelia and squamous cell carcinomas of the head and neck and the lower female genital tract. Journal of Oral Pathology and Medicine. 19(9). 408–413. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact